Literature DB >> 30621498

Key indicators of organized cancer screening programs: Results from a Delphi study.

Marcell Csanádi1, Inge McM de Kok2, Eveline Am Heijnsdijk2, Ahti Anttila3, Sirpa Heinävaara3, János G Pitter1, György Széles1, Urška Ivanuš4, Jennifer Priaulx5, Piret Veerus6, Carlo Senore7, Harry J de Koning2, Zoltán Vokó1.   

Abstract

Entities:  

Keywords:  Delphi study; European screening experts; Organized screening program; breast cancer screening; cervical cancer screening; colorectal cancer screening; indicators of screening

Mesh：

Year:  2019        PMID： 30621498     DOI： 10.1177/0969141318820362

Source DB:  PubMed          Journal:  J Med Screen        ISSN： 0969-1413            Impact factor:   2.136


× No keyword cloud information.
  3 in total

1.  Cervical screening in Western Kazakhstan: Liquid-based cytology 'Cell Scan' versus azur-eosin staining.

Authors:  Saule Balmagambetova; Giovanni Gabutti; Arip Koyshybaev; Cecilia Acuti Martellucci; Olzhas Urazayev; Kanshaiym Sakiyeva; Karlygash Bekova
Journal:  J Med Screen       Date:  2019-11-20       Impact factor: 2.136

2.  The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe.

Authors:  Andrea Gini; Nicolien T van Ravesteyn; Erik E L Jansen; Eveline A M Heijnsdijk; Carlo Senore; Ahti Anttila; Dominika Novak Mlakar; Piret Veerus; Marcell Csanádi; Nadine Zielonke; Sirpa Heinävaara; György Széles; Nereo Segnan; Harry J de Koning; Iris Lansdorp-Vogelaar
Journal:  Prev Med Rep       Date:  2021-04-30

3.  Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.

Authors:  Sergei Muratov; Carlos Canelo-Aybar; Jean-Eric Tarride; Pablo Alonso-Coello; Nadya Dimitrova; Bettina Borisch; Xavier Castells; Stephen W Duffy; Patricia Fitzpatrick; Markus Follmann; Livia Giordano; Solveig Hofvind; Annette Lebeau; Cecily Quinn; Alberto Torresin; Claudia Vialli; Sabine Siesling; Antonio Ponti; Paolo Giorgi Rossi; Holger Schünemann; Lennarth Nyström; Mireille Broeders
Journal:  BMC Cancer       Date:  2020-08-24       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.